Inhibition of MGAT2 modulates fat‐induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high‐fat diet
Monoacylglycerol O‐acyltransferase 2 (MGAT2) is one of the key enzymes responsible for triglyceride (TG) re‐synthesis in the small intestine. We have previously demonstrated that pharmacological inhibition of MGAT2 has beneficial effects on obesity and metabolic disorders in mice. Here, we further i...
Main Authors: | Taisuke Mochida, Kazumi Take, Toshiyuki Maki, Masanori Nakakariya, Ryutaro Adachi, Kenjiro Sato, Tomoyuki Kitazaki, Shiro Takekawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.12778 |
Similar Items
-
MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice
by: Tsuchida Takuma, et al.
Published: (2012-06-01) -
Expression of mouse MGAT in Arabidopsis results in increased lipid accumulation in seeds
by: Anna eEl Tahchy, et al.
Published: (2015-12-01) -
Catalytic properties of MGAT3, a putative triacylgycerol synthases⃞
by: Jingsong Cao, et al.
Published: (2007-03-01) -
Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2−/−) or obese (ob/ob) mice
by: Anil K. Agarwal, et al.
Published: (2016-04-01) -
Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain
by: David W. Nelson, et al.
Published: (2011-09-01)